Back to All NewsBTL Makes History With One-Millionth Emsculpt Patient Milestone
Posted By American Med Spa Association, Wednesday, November 10, 2021
Share
BTL, an authority in non-invasive body sculpting therapies, announced that its Emsculpt family of products is the fastest aesthetic device brand to reach one million treatments as indicated by Medical Insights.
With over 3,400 units installed globally, 30+ peer-reviewed publications on HIFEM technology, and over 25 billion media impressions, the Emsculpt Classic and Emsculpt NEO body sculpting treatments have made their marks as leaders in the aesthetic device industry. Globally, an average of 21 Emsculpt Classic treatments/unit and 39 Emsculpt NEO treatments/unit are administered each month.
According to John Ferris, BTL Aesthetics Vice President of US Marketing, "In just over three years, we have achieved what no other aesthetic device brand has done. We've accomplished this milestone with the support of all our stakeholders and the trust consumers put in the Emsculpt brand and providers. We didn't rely on virtual consumables to drive consumer awareness. The awareness was earned through studies and patient outcomes. Truly, this achievement is not only history in the making, but a testament to the efficacy and impact of Emsculpt and Emsculpt NEO."
Read more at PR Newswire >>
With over 3,400 units installed globally, 30+ peer-reviewed publications on HIFEM technology, and over 25 billion media impressions, the Emsculpt Classic and Emsculpt NEO body sculpting treatments have made their marks as leaders in the aesthetic device industry. Globally, an average of 21 Emsculpt Classic treatments/unit and 39 Emsculpt NEO treatments/unit are administered each month.
According to John Ferris, BTL Aesthetics Vice President of US Marketing, "In just over three years, we have achieved what no other aesthetic device brand has done. We've accomplished this milestone with the support of all our stakeholders and the trust consumers put in the Emsculpt brand and providers. We didn't rely on virtual consumables to drive consumer awareness. The awareness was earned through studies and patient outcomes. Truly, this achievement is not only history in the making, but a testament to the efficacy and impact of Emsculpt and Emsculpt NEO."
Read more at PR Newswire >>
